NO20070598L - Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem - Google Patents

Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem

Info

Publication number
NO20070598L
NO20070598L NO20070598A NO20070598A NO20070598L NO 20070598 L NO20070598 L NO 20070598L NO 20070598 A NO20070598 A NO 20070598A NO 20070598 A NO20070598 A NO 20070598A NO 20070598 L NO20070598 L NO 20070598L
Authority
NO
Norway
Prior art keywords
colorectal
carcinoma
colorectal adenoma
biomarker
well
Prior art date
Application number
NO20070598A
Other languages
English (en)
Inventor
Hartmut Juhl
Kerstin David
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070598(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of NO20070598L publication Critical patent/NO20070598L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det beskrives en framgangsmåte for å detektere kolorektal adenom og / eller kolorektal karsinom omfattende trinnene: a) tilveiebringe et isolert prøvemateriale · som har blitt hentet fra et individ, b) bestemme nivået av transtyretin i nevnte isolerte prøvemateriale, og c) sammenlikne det bestemte nivå av transtyretin med en referanseverdi. Det beskrives videre en framgangsmåte for å diskriminere mellom kolorektal adenom og kolorektal karsinom og likeledes en framgangsmåte for åmonitorere forløpet av kolorektal adenom og / eller kolorektal karsinom og / eller behandlingen av kolorektal adenom og / eller kolorektal karsinom. Videre beskrives et testsystem og et array for anvendelse i disse metoder. Videre vedrører oppfinnelsen anvendelse av transtyretin som en biomarkør for deteksjon av kolorektal adenom og/eller kolorektal karsinom i et individ.
NO20070598A 2004-08-13 2007-01-31 Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem NO20070598L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
NO20070598L true NO20070598L (no) 2007-05-14

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20070598A NO20070598L (no) 2004-08-13 2007-01-31 Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
NO20070599A NO20070599L (no) 2004-08-13 2007-01-31 Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20070599A NO20070599L (no) 2004-08-13 2007-01-31 Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.

Country Status (20)

Country Link
US (2) US7951528B2 (no)
EP (3) EP1843159A1 (no)
JP (2) JP4916441B2 (no)
KR (1) KR20070051328A (no)
CN (2) CN101014859A (no)
AT (2) ATE376674T1 (no)
AU (2) AU2004322162B2 (no)
BR (1) BRPI0419002A (no)
CA (2) CA2577601A1 (no)
DE (2) DE602004009716T2 (no)
DK (2) DK1761779T3 (no)
ES (2) ES2295907T3 (no)
IL (2) IL181132A (no)
MX (2) MX2007001479A (no)
NO (2) NO20070598L (no)
PL (2) PL1761779T3 (no)
PT (2) PT1761779E (no)
SI (1) SI1776587T1 (no)
WO (2) WO2006015616A1 (no)
ZA (1) ZA200701188B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2577601A1 (en) 2004-08-13 2006-02-16 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2009025080A1 (ja) * 2007-08-18 2009-02-26 School Juridical Person Kitasato Institute 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
BR112015012616A2 (pt) * 2012-11-30 2017-09-12 Applied Proteomics Inc método para avaliação da presença ou risco de tumores de cólon
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
US20170176441A1 (en) * 2014-03-28 2017-06-22 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
CN107110865B (zh) * 2014-08-22 2020-01-10 雅培制药有限公司 用于结肠直肠癌的早期检测的方法
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
US20020160394A1 (en) 2001-01-24 2002-10-31 Bayer Corporation Regulation of transthyretin to treat obesity
WO2003000182A2 (en) 2001-06-22 2003-01-03 Merck & Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
US20060199179A1 (en) 2002-06-19 2006-09-07 Oncotherapy Science, Inc. Method for diagnosis of colorectal tumors
EP1540010B8 (en) 2002-08-06 2010-07-14 The Johns Hopkins University Use of biomarkers for detecting ovarian cancer
EP1613966A2 (en) * 2003-04-08 2006-01-11 Colotech A/S A method for detection of colorectal cancer in human samples
US7268117B2 (en) * 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
DK1776464T3 (da) 2004-08-13 2010-02-01 Egomedical Technologies Ag analyt.-testsytem til bestemmelse af koncentrationen af en analyt i en fysiologisk eller vandig væske
CA2577601A1 (en) * 2004-08-13 2006-02-16 Indivumed Gmbh Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
CA2576998A1 (en) 2006-05-26
SI1776587T1 (sl) 2009-06-30
ATE376674T1 (de) 2007-11-15
IL181131A (en) 2011-03-31
MX2007001479A (es) 2007-07-25
EP1761779B1 (en) 2007-10-24
EP1776587A1 (en) 2007-04-25
US20070184499A1 (en) 2007-08-09
PT1761779E (pt) 2008-02-01
EP1776587B9 (en) 2009-09-16
PL1776587T3 (pl) 2009-06-30
CA2577601A1 (en) 2006-02-16
KR20070051328A (ko) 2007-05-17
JP2008509407A (ja) 2008-03-27
AU2004322162A1 (en) 2006-02-16
NO20070599L (no) 2007-05-14
DE602004009716D1 (de) 2007-12-06
EP1843159A1 (en) 2007-10-10
JP4916441B2 (ja) 2012-04-11
DK1776587T3 (da) 2009-04-20
MX2007001254A (es) 2007-10-05
ES2322378T3 (es) 2009-06-19
WO2006053592A1 (en) 2006-05-26
ATE419534T1 (de) 2009-01-15
ES2295907T3 (es) 2008-04-16
IL181131A0 (en) 2007-07-04
EP1761779A1 (en) 2007-03-14
DK1761779T3 (da) 2008-02-25
WO2006015616A1 (en) 2006-02-16
AU2005306103A1 (en) 2006-05-26
PT1776587E (pt) 2009-04-03
DE602005012108D1 (de) 2009-02-12
AU2004322162A2 (en) 2006-02-16
CN101014861A (zh) 2007-08-08
US7883842B2 (en) 2011-02-08
BRPI0419002A (pt) 2007-12-11
DE602004009716T2 (de) 2008-08-28
AU2004322162B2 (en) 2011-04-28
JP4592753B2 (ja) 2010-12-08
JP2008509409A (ja) 2008-03-27
EP1776587B1 (en) 2008-12-31
IL181132A0 (en) 2007-07-04
PL1761779T3 (pl) 2008-04-30
ZA200701188B (en) 2009-01-28
IL181132A (en) 2011-04-28
US7951528B2 (en) 2011-05-31
US20080160515A1 (en) 2008-07-03
CN101014859A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
NO20070598L (no) Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
WO2007035676A3 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
WO2008095152A3 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
RU2018124339A (ru) Способ и система для сенсорного обнаружения посредством модифицированной наноструктуры
WO2013049782A3 (en) System, apparatus and method for evaluating samples or analytes using a point-of-care device
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2004030511A3 (en) Prostate cancer biomarkers
WO2007005666A3 (en) System and method of analyte detection using differential receptors
WO2004034056A3 (en) Portable diagnostic device and method for determining temporal variations in concentrations
EP1415152A4 (en) METHOD, DEVICES AND COMPUTER PROGRAMS FOR VERIFYING THE INTEGRITY OF A PROBE
MX2021008520A (es) Metodos y sistemas para deteccion de analitos.
JP2020514689A5 (no)
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis
NO20080510L (no) Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon
WO2004058051A3 (en) Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
WO2006019991A3 (en) Method and apparatus for multimodal detection
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
EP2017642A3 (fr) Procédé et dispositif de détection et de mesure de paramètres de signaux radioélectriques
MX2017008959A (es) Biomarcadores relacionados con la funcion del riñon y metodos que involucran su uso.
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal
WO2008060676A3 (en) System and method for resolving gamma-ray spectra
ES2530618T3 (es) Método para discriminar entre carcinoma pulmonar en fase temprana y avanzada

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application